Answer: lithotripsy
Explanation:
Kidney stones can be define as one of the urogenital disorders. There is no reason for the formation of kidney stones. Typically the adults which are over the age of 40 and males are more susceptible to the develop kidney stones.
The lithotripsy is a non-invasive technique which utilizes the shock waves so as to break the stones present in the kidneys into small pieces so that they can be easily pass through the body by urine.
Breaches of unsecured PHI are put through a risk assessment test to determine if they must be reported the assessment considers to determine the probability that PHI has been compromised.
Breach is low - risk , don't have to notify affected parties , but there is a greater than low risk. The acquisition or use or disclosure of PHI in a way that compromises the security or privacy of PHI,also risk of financial , reputation, or harm individual.
According to HIPAA's rule - it covered entities to notify parents when their unsecured protected health information is used or disclosed or it may be breached in a way that compromise the privacy and security of it.
To learn more about HIPAA's rule here
brainly.com/question/15223675
#SPJ4
Answer:
Yes, both Coumadin and Heparin can be given at the same time.
Explanation:
Both Coumadin and Heparin can be given at the same time. Heparin is is a blood thinner (anti-coagulant) used to prevent and treat blood clots.The patient has been diagnosed with Deep Vein Thrombosis (DVT) which is the formation of blood clot in a vein located deep in the body (usually the lower thigh or leg). The heparin drip she is being administered will help treat the blood clot
Coumadin is also an anticoagualnt and is used for treating blood clotts. However, it takes days (about 3-4) before the treatment starts to work. It stops the synthesis of the four vitamin K–dependent clotting factors in the liver (factors II, VII, IX, X).
Both Heparin and Coumadin are overlapped for at least five days as they work differently. The Heparin is discontinued after anticoagulation occurs and the client starts to be treated with coumadin.
Patents on allergy relief medications like Allegra and Claritin give the pharmaceutical companies that own the patents a sustainable competitive advantage for 17 years until the patent expires.
A sustainable competitive advantage is one which cannot be duplicated by the competitors of a pharmaceutical company, particularly in this instance, at the minimum up to the expiry of the patent.
A competitive advantage is a collection of distinctive characteristics of a company as well as its products which are recognized by the target market as noteworthy and superlative to the competition.
It can include factor or factors due to which the customers are liable to patronize a particular company and not its competition.
To learn more about sustainable competitive advantage here
brainly.com/question/5647002
#SPJ4
